MENU
BIOA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioAge Labs (BIOA) Ownership - Who owns BioAge Labs?
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
170.65M
P/E Ratio
N/A
Total Cash
297.3M
Projected Growth
N/A
Total Debt
8.75M
Revenue
3.86M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.29
Total Debt/Equity
53.55
Revenue/Share
0.11 USD as % of share price
Fundamentals
BIOA
Capitalization
171M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
297M
Total Cash/Share
8.29
Total Debt
8.75M
Total Debt/Equity
53.55
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
3.86M
ROE
N/A
Book Value
295M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
-6.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
13.21
Current Revenue Per Employee
37687.50
Dividends Per Share - Security
N/A
EBITDA
-77.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.48
Shares Held By Institutions
75M
Shares Outstanding - Current
35.9M
Total Liabilities
27.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.789
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a producer of sustainable chemicals
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A